Clinical Trial Update: DX-8951f in Treating Patients With Biliary Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of the investigational drug DX-8951f in biliary tract cancers has completed, evaluating extrahepatic cholangiocarcinoma and gallbladder cancer (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma Extrahepatic
• Gallbladder Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• DX-8951f

Snippet

Sponsor: Daiichi Sankyo | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 2 | Status: COMPLETED